Tracing Spatiotemporal T790M Heterogeneity in Patients with EGFR-Mutant Advanced NSCLC after Acquired Resistance to EGFR TKIs

被引：0
|
作者：
Zhang, Yi-Chen
Pi, Can
Ke, E-E
Chen, Zhi-Hong
Su, Jian
Dong, Zhong-Yi
Xu, Chong-Rui
Tu, Hai-Yan
Yan, Hong-Hong
Zhong, Wen-Zhao
Yang, Jin-Ji
Zhang, Xu-Chao
Wu, Yi Long
Zhou, Qing
机构：
[1] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] GGH, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Acquired resistance; EGFR TKIs; spatiotemporal heterogeneity; T790M;
D O I：
10.1016/j.jtho.2016.11.1762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-095
引用
收藏
页码：S1249 / S1249
页数：1
相关论文
共 50 条
  • [31] The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613
    Remon, Jordi
    Menis, Jessica
    Hasan, Baktiar
    Peric, Aleksandra
    De Maio, Eleonora
    Novello, Silvia
    Reck, Martin
    Berghmans, Thierry
    Wasag, Bartosz
    Besse, Benjamin
    Dziadziuszko, Rafal
    CLINICAL LUNG CANCER, 2017, 18 (05) : 583 - 588
  • [32] Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients
    Kuiper, J. L.
    Heideman, D. A. M.
    Thunnissen, E.
    Paul, M. A.
    van Wijk, A. W.
    Postmus, P. E.
    Smit, E. F.
    LUNG CANCER, 2014, 85 (01) : 19 - 24
  • [33] Prognostic factors influencing overall survival in stage IV EGFR-mutant NSCLC patients treated with EGFR-TKIs
    Kuang, Linwu
    Zhang, Yuchen
    Wang, Hao
    Wang, Peng
    Li, Yangkai
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [34] Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition
    Soucheray, Margaret
    Capelletti, Marzia
    Pulido, Ines
    Kuang, Yanan
    Paweletz, Cloud P.
    Becker, Jeffrey H.
    Kikuchi, Eiki
    Xu, Chunxiao
    Patel, Tarun B.
    Al-Shahrour, Fatima
    Carretero, Julian
    Wong, Kwok-Kin
    Jaenne, Pasi A.
    Shapiro, Geoffrey I.
    Shimamura, Takeshi
    CANCER RESEARCH, 2015, 75 (20) : 4372 - 4383
  • [35] EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs
    Liang, Zhiyong
    Cheng, Ying
    Chen, Yuan
    Hu, Yanping
    Liu, Wei-Ping
    Lu, You
    Wang, Jie
    Wang, Ye
    Wu, Gang
    Ying, Jian-Ming
    Zhang, He-Long
    Zhang, Xu-Chao
    Wu, Yi-Long
    CANCER LETTERS, 2017, 403 : 186 - 194
  • [36] EGFR-TKIs Combined Hydroxycamptothecin Improved Outcomes in EGFR-Mutant NSCLC Patients Who Harboring Pericardial Effusion
    Wang, X.
    Yao, J.
    Guo, R.
    Lu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S985 - S985
  • [37] Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
    Li, Ling
    Wang, Tao
    Hu, Mengdi
    Zhang, Yali
    Chen, Hongzhuan
    Xu, Lu
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients
    Li, Wei
    Ren, Shengxiang
    Li, Jiayu
    Li, Aiwu
    Fan, Lihong
    Li, Xuefei
    Zhao, Cao
    He, Yayi
    Gao, Guanghui
    Chen, Xiaoxia
    Li, Shuai
    Shi, Jingyun
    Zhou, Caicun
    Fei, Ke
    Schmid-Bindert, Gerald
    LUNG CANCER, 2014, 84 (03) : 295 - 300
  • [39] Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) in EGFR-Mutant Lung Adenocarcinoma among Hispanics (Rbiop-CLICaP)
    Cardona, Andres
    Arrieta, Oscar
    Rojas, Leonardo
    Wills, Beatriz
    Reguart, Noemi
    Carranza, Hernan
    Vargas, Carlos
    Otero, Jorge
    Archila, Pilar
    Martin, Claudio
    Corrales, Luis
    Cuello, Mauricio
    Ortiz, Carlos
    Franco, Sandra
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S517 - S518
  • [40] Concomitant genetic alterations having greater impact on the clinical benefit of EGFR-TKIs in EGFR-mutant advanced NSCLC than BIM deletion polymorphism
    Liu, Si-Yang
    Zhou, Jia-Ying
    Li, Wen-Feng
    Sun, Hao
    Zhang, Yi-Chen
    Yan, Hong-Hong
    Chen, Zhi-Hong
    Chen, Chun-Xiang
    Ye, Jun-Yi
    Yang, Jin-Ji
    Zhou, Qing
    Zhang, Xu-Chao
    Wu, Yi-Long
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (01): : 337 - 345
12345